Impaired Virus Clearance, Compromised Immune Response and Increased Mortality in Type 2 Diabetic Mice Infected with West Nile Virus

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Kumar, Mukesh ^a   Roe, Kelsey ^a   Nerurkar, Pratibha V ^a   Namekar, Madhuri ^a   Orillo, Beverly ^a   Verma, Saguna ^a   Nerurkar, Vivek R ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GLUCOSE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LEPTIN RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BODY WEIGHT; BRAIN; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEART; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INFLAMMATION; INTERFERON INDUCTION; KIDNEY; LIVER; LUNG; MORTALITY; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; SPLEEN; VIRAL CLEARANCE; VIRUS REPLICATION; VIRUS TITRATION; WEST NILE FEVER; WEST NILE FLAVIVIRUS;

ADIPOSE TISSUE; ANIMALS; ANTIBODIES, VIRAL; ANTIBODY FORMATION; BODY WEIGHT; BRAIN; CHEMOKINES; DIABETES MELLITUS, TYPE 2; DISEASE SUSCEPTIBILITY; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; IMMUNITY; INTERFERON-ALPHA; KINETICS; MICE; MICE, INBRED C57BL; SPECIES SPECIFICITY; SURVIVAL ANALYSIS; VIRAL LOAD; VIRUS REPLICATION; WEST NILE FEVER; WEST NILE VIRUS;

MUS; WEST NILE VIRUS;

EID: 84865660565     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044682     Document Type: Article

References (52)

1. Calvet HM, Yoshikawa TT (2001) Infections in diabetes. Infect Dis Clin North Am 15: 407-421, viii.
2. Joshi N, Caputo GM, Weitekamp MR, Karchmer AW, (1999) Infections in patients with diabetes mellitus. N Engl J Med 341: 1906-1912.
3. Peleg AY, Weerarathna T, McCarthy JS, Davis TM, (2007) Common infections in diabetes: pathogenesis, management and relationship to glycaemic control. Diabetes Metabol Res Rev 23: 3-13.
4. Tanowitz HB, Amole B, Hewlett D, Wittner M, (1988) Trypanosoma cruzi infection in diabetic mice. Trans R Soc Trop Med Hyg 82: 90-93.
5. Park S, Rich J, Hanses F, Lee JC, (2009) Defects in innate immunity predispose C57BL/6J-Leprdb/Leprdb mice to infection by Staphylococcus aureus. Infect Immun 77: 1008-1014.
6. Ikejima S, Sasaki S, Sashinami H, Mori F, Ogawa Y, et al. (2005) Impairment of host resistance to Listeria monocytogenes infection in liver of db/db and ob/ob mice. Diabetes 54: 182-189.
7. Geerlings SE, Hoepelman AI, (1999) Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol 26: 259-265.
8. Naguib G, Al-Mashat H, Desta T, Graves DT, (2004) Diabetes prolongs the inflammatory response to a bacterial stimulus through cytokine dysregulation. J Invest Dermatol 123: 87-92.
9. Donath MY, Shoelson SE, (2011) Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11: 98-107.
10. Hayes EB, Gubler DJ, (2006) West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States. Annu Rev Med 57: 181-194.
11. Nash D, Mostashari F, Fine A, Miller J, O'Leary D, et al. (2001) The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 344: 1807-1814.
12. Sejvar JJ, Lindsey NP, Campbell GL, (2011) Primary causes of death in reported cases of fatal West Nile Fever, United States, 2002-2006. Vector Borne Zoonotic Dis 11: 161-164.
13. Patnaik JL, Harmon H, Vogt RL, (2006) Follow-up of 2003 human West Nile virus infections, Denver, Colorado. Emerg Infect Dis 12: 1129-1131.
14. Jean CM, Honarmand S, Louie JK, Glaser CA, (2007) Risk factors for West Nile virus neuroinvasive disease, California, 2005. Emerg Infect Dis 13(12): 1918-20.
15. Bode AV, Sejvar JJ, Pape WJ, Campbell GL, Marfin AA, (2006) West Nile virus disease: a descriptive study of 228 patients hospitalized in a 4-county region of Colorado in 2003. Clin Infect Dis 42: 1234-1240.
16. Abroug F, Ouanes-Besbes L, Letaief M, Ben Romdhane F, Khairallah M, et al. (2006) A cluster study of predictors of severe West Nile virus infection. Mayo Clin Proc 81: 12-16.
17. Cook RL, Xu X, Yablonsky EJ, Sakata N, Tripp JH, et al. (2010) Demographic and clinical factors associated with persistent symptoms after West Nile virus infection. Am J Trop Med Hyg 83: 1133-1136.
18. Khairallah M, Yahia SB, Letaief M, Attia S, Kahloun R, et al. (2007) A prospective evaluation of factors associated with chorioretinitis in patients with West Nile virus infection. Ocul Immunol Inflamm 15: 435-439.
19. Teitelbaum BA, Newman TL, Tresley DJ, (2007) Occlusive retinal vasculitis in a patient with West Nile virus. Clinical & experimental optometry: Clin Exp Optom 90: 463-467.
20. Garcia-Tapia D, Hassett DE, Mitchell WJ Jr, Johnson GC, Kleiboeker SB, (2007) West Nile virus encephalitis: sequential histopathological and immunological events in a murine model of infection. J Neurovirol 13: 130-138.
21. Wang T, Town T, Alexopoulou L, Anderson JF, Fikrig E, et al. (2004) Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 10: 1366-1373.
22. Samuel MA, Diamond MS, (2005) Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J Virol 79: 13350-13361.
23. Diamond MS, Sitati EM, Friend LD, Higgs S, Shrestha B, et al. (2003) A critical role for induced IgM in the protection against West Nile virus infection. J Exp Med 198: 1853-1862.
24. Diamond MS, Shrestha B, Marri A, Mahan D, Engle M, (2003) B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J Virol 77: 2578-2586.
25. Shrestha B, Diamond MS, (2004) Role of CD8+ T cells in control of West Nile virus infection. J Virol 78: 8312-8321.
26. Sitati EM, Diamond MS, (2006) CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system. J Virol 80: 12060-12069.
27. Kumar M, Verma S, Nerurkar VR, (2010) Pro-inflammatory cytokines derived from West Nile virus (WNV)-infected SK-N-SH cells mediate neuroinflammatory markers and neuronal death. J Neuroinflammation 7: 73.
28. Klein RS, Lin E, Zhang B, Luster AD, Tollett J, et al. (2005) Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis. J Virol 79: 11457-11466.
29. Shrestha B, Zhang B, Purtha WE, Klein RS, Diamond MS, (2008) Tumor necrosis factor alpha protects against lethal West Nile virus infection by promoting trafficking of mononuclear leukocytes into the central nervous system. J Virol 82: 8956-8964.
30. Leiter EH, (1981) The influence of genetic background on the expression of mutations at the diabetes locus in the mouse IV. Male lethal syndrome in CBA/Lt mice. Diabetes 30: 1035-1044.
31. Brown AN, Kent KA, Bennett CJ, Bernard KA, (2007) Tissue tropism and neuroinvasion of West Nile virus do not differ for two mouse strains with different survival rates. Virology 368: 422-430.
32. Webb SR, Loria RM, Madge GE, Kibrick S, (1976) Susceptibility of mice to group B coxsackie virus is influenced by the diabetic gene. J Exp Med 143: 1239-1248.
33. Desruisseaux MS, Nagajyothi, Trujillo ME, Tanowitz HB, Scherer PE, (2007) Adipocyte, adipose tissue, and infectious disease. Infect Immun 75: 1066-1078.
34. Bouwman JJ, Visseren FL, Bouter KP, Diepersloot RJ, (2008) Infection-induced inflammatory response of adipocytes in vitro. Int J Obes 32: 892-901.
35. Dhurandhar NV, Kulkarni PR, Ajinkya SM, Sherikar AA, Atkinson RL, (1997) Association of adenovirus infection with human obesity. Obesity research 5: 464-469.
36. Combs TP, Nagajyothi F, Mukherjee S, de Almeida CJ, Jelicks LA, et al. (2005) The adipocyte as an important target cell for Trypanosoma cruzi infection. Biol Chem 280: 24085-24094.
37. Bechah Y, Paddock CD, Capo C, Mege JL, Raoult D, (2010) Adipose tissue serves as a reservoir for recrudescent Rickettsia prowazekii infection in a mouse model. PloS One 5: e8547.
38. Murray K, Walker C, Herrington E, Lewis JA, McCormick J, et al. (2010) Persistent infection with West Nile virus years after initial infection. J Infect Dis 201: 2-4.
39. Appler KK, Brown AN, Stewart BS, Behr MJ, Demarest VL, et al. (2010) Persistence of West Nile virus in the central nervous system and periphery of mice. PLoS One 5: e10649.
40. Samuel MA, Diamond MS, (2006) Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion. J Virol 80: 9349-9360.
41. Le Bon A, Schiavoni G, D'Agostino G, Gresser I, Belardelli F, et al. (2001) Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 14: 461-470.
42. Purtha WE, Chachu KA, Virgin HWT, Diamond MS, (2008) Early B-cell activation after West Nile virus infection requires alpha/beta interferon but not antigen receptor signaling. J Virol 82: 10964-10974.
43. Deonarain R, Cerullo D, Fuse K, Liu PP, Fish EN, (2004) Protective role for interferon-beta in coxsackievirus B3 infection. Circulation 110: 3540-3543.
44. Smith AG, Sheridan PA, Harp JB, Beck MA, (2007) Diet-induced obese mice have increased mortality and altered immune responses when infected with influenza virus. J Nutr 137: 1236-1243.
45. Byrne SN, Halliday GM, Johnston LJ, King NJ, (2001) Interleukin-1beta but not tumor necrosis factor is involved in West Nile virus-induced Langerhans cell migration from the skin in C57BL/6 mice. J Invest Dermatol 117: 702-709.
46. Alexandraki K, Piperi C, Kalofoutis C, Singh J, Alaveras A, et al. (2006) Inflammatory process in type 2 diabetes: The role of cytokines. Ann N Y Acad Sci 1084: 89-117.
47. O'Connor JC, Satpathy A, Hartman ME, Horvath EM, Kelley KW, et al. (2005) IL-1beta-mediated innate immunity is amplified in the db/db mouse model of type 2 diabetes. J Immunol 174: 4991-4997.
48. Nagajyothi F, Zhao D, Machado FS, Weiss LM, Schwartz GJ, et al. (2010) Crucial role of the central leptin receptor in murine Trypanosoma cruzi (Brazil strain) infection. J Infect Dis 202: 1104-1113.
49. Roe K, Kumar M, Lum S, Orillo B, Nerurkar VR, et al. (2012) West Nile virus-induced disruption of the blood-brain barrier in mice is characterized by the degradation of the junctional complex proteins and increase in multiple matrix metalloproteinases. J Gen Virol 93(Pt 6): 1193-203.
50. Lanteri MC, O'Brien KM, Purtha WE, Cameron MJ, Lund JM, et al. (2009) Tregs control the development of symptomatic West Nile virus infection in humans and mice. J Clin Invest 119: 3266-3277.
51. Verma S, Lo Y, Chapagain M, Lum S, Kumar M, et al. (2009) West Nile virus infection modulates human brain microvascular endothelial cells tight junction proteins and cell adhesion molecules: Transmigration across the in vitro blood-brain barrier. Virology 385: 425-433.
52. Nerurkar PV, Nishioka A, Eck PO, Johns LM, Volper E, et al. (2011) Regulation of glucose metabolism via hepatic forkhead transcription factor 1 (FoxO1) by Morinda citrifolia (noni) in high-fat diet-induced obese mice. Br J Nutr: 1-11.